We next determined the levels of c-Myc in the combination treatment and observed that c-Myc levels were inhibited by SPARC overexpression, thereby indicating a role of PI3K/AKT signaling in neuroblastoma cell proliferation. This evidence concerns the gene MYC and neuroblastoma.